U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Etomidate Injection
Status: Currently in Shortage
»Date first posted: 10/05/2022
»Therapeutic Categories: Anesthesia

Expand all

Caplin Steriles, Ltd. (Reverified 04/08/2024)

Company Contact Information:
Check Marketing Partner

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 2 mg/1 mL (NDC 65219-445-10) Available Check wholesalers for inventory; Marketed by Fresenius Kabi

Fresenius Kabi Etomidate Shelf Life Extension Letter


Search List of Extended Use Dates to Assist with Drug Shortages
Injection, 40 mg/20 mL (NDC 65219-445-20) Available Check wholesalers for inventory; Marketed by Fresenius Kabi

Fresenius Kabi Etomidate Shelf Life Extension Letter


Search List of Extended Use Dates to Assist with Drug Shortages
Injection, 2 mg/1 mL (NDC 25021-674-10) Available Marketed by Sagent
Injection, 2 mg/1 mL (NDC 25021-674-20) Available Marketed by Sagent

Eugia US LLC (Reverified 05/21/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 20 mg/10 mL (NDC 55150-221-10) Available Check wholesalers for inventory
Injection, 40 mg/20 mL (NDC 55150-222-20) Available Check wholesalers for inventory

Gland Pharma Limited (Reverified 03/15/2024)

Company Contact Information:
866-733-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) Available Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) Available Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Hikma Pharmaceuticals USA, Inc. (Reverified 05/23/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Etomidate Injection, USP, Injection, 2 mg/1 mL (NDC 0143-9506-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Etomidate Injection, USP, Injection, 2 mg/1 mL (NDC 0143-9507-10) Available Additional lots will be available. Product will be made available as it is released.
Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) Pending information
Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) Pending information
Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) Pending information Distributed by Civica
Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) Pending information Distributed by Civica

Hospira, Inc., a Pfizer Company (Revised 06/13/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) Available
Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) Available

Mylan Institutional, a Viatris Company (Reverified 05/30/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) Available
Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) Available
Back to Top